We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell t... Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is currently in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). Capricor is also developing its exosome technology as a next-generation therapeutic platform. Capricor's proprietary StealthX¿ exosome platform has potential for a broad range of new therapeutic applications in the field of vaccinology as well as targeted oligonucleotide, protein and small molecule therapeutics to treat or prevent a variety of diseases. Show more
--Results in Performance of the Upper Limb (PUL 2.0) Continue to Show Benefits in Skeletal Muscle Function After 3 Years of CAP-1002 Treatment (p< 0.001)-- --Stabilization in Left Ventricular...
βPhase 3, HOPE-3 Trial (Cohort A) of CAP-1002 inΒ Duchenne Muscular Dystrophy Fully Enrolled; On Track to Report Top-Line Data in Q4 2024β βPositive Type-B CMC FDA Meeting held in Q1; Company...
-Preclinical findings show exosome-based therapeutic approach for the treatment of arginase-1 deficiency (ARG1-D)- -Presentation to be featured in an oral session being held on May 9, 2024- SAN...
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.21 | -3.49417637271 | 6.01 | 6.15 | 5.41 | 449886 | 5.71594364 | CS |
4 | 0.22 | 3.94265232975 | 5.58 | 6.5336 | 5 | 366928 | 5.7485772 | CS |
12 | 0.01 | 0.172711571675 | 5.79 | 7.28 | 4.685 | 373764 | 5.90334786 | CS |
26 | 2.81 | 93.9799331104 | 2.99 | 7.28 | 2.99 | 313398 | 5.25184488 | CS |
52 | 1.25 | 27.4725274725 | 4.55 | 8.2212 | 2.68 | 249060 | 4.88568623 | CS |
156 | 1.85 | 46.835443038 | 3.95 | 8.2212 | 2.56 | 256308 | 4.65410679 | CS |
260 | 5.509 | 1893.12714777 | 0.291 | 12.32 | 0.291 | 764060 | 5.92029231 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions